World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01234363
Date of registration: 26/07/2010
Prospective Registration: No
Primary sponsor: Hospices Civils de Lyon
Public title: Renal Allograft : Evaluation of Parenchymal Fibrosis by Elastography GREFE
Scientific title: Evaluation of the Potential of Elastography for Noninvasive Assessment of Fibrosis in Kidney Transplant
Date of first enrolment: May 2010
Target sample size: 60
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01234363
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     ROUVIERE Olivier, Pr
Address: 
Telephone: 4 72 11 09 51
Email: olivier.rouviere@netcourrier.com
Affiliation: 
Name:     ROUVIERE Olivier, Pr
Address: 
Telephone:
Email:
Affiliation:  Hospices Civils de Lyon Service de Radiologie, Pavillon P Radio, Hôpital Edouard Herriot, 69437 Lyon Cedex 03
Name:     ROUVIERE Olivier, Pr
Address: 
Telephone: 472 11 09 51
Email: olivier.rouviere@netcourrier.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Renal allograft performed less than 3 months before enrolment

Exclusion Criteria:

- Contra-indication to magnetic resonance imaging

- Contra-indication to biopsy



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Renal Transplant
Intervention(s)
Device: Magnetic Resonance Elastography, and Supersonic Shear Imaging
Primary Outcome(s)
Correlation between elasticity (as measured by elastography) and (a) Banff score for fibrosis, (b) glomerular filtration rate assessed by creatinine clearance, (c) glomerular filtration rate assessed by insulin clearance [Time Frame: 3 months and 12 months after graft]
Secondary Outcome(s)
Tolerance (assessed by a questionnaire) [Time Frame: 3 months and 12 months after graft]
Number of technical failures [Time Frame: 12 months]
Correlation between elasticity and arterial resistance index [Time Frame: 3 months and 12 months after graft]
Evolution of the elasticity of the transplant between 3 and 12 months after graft [Time Frame: 3 months and 12 months after graft]
Secondary ID(s)
2009.590
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history